INSP Earnings Date: Nov 2, 2026 (Estimated) — Inspire Medical Systems, Inc.
NYSE · Healthcare · Medical Devices
Updated
When is INSP's next earnings date?
Inspire Medical Systems, Inc. (INSP) is expected to report Q3 2026 earnings on Monday, November 2, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.09 on revenue of $204.3M.
How did INSP do in its last earnings report?
In its most recent report on Aug 3, 2026 (Q2 2026), Inspire Medical Systems, Inc. posted EPS of $0.14 versus the -$0.24 estimate, a beat of 158.3%. Revenue was $200.6M against a $194.7M estimate. The stock's 1-day post-earnings move was +22.8%.
How much does INSP stock move after earnings?
INSP beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.7% (up or down) in the day after earnings.
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 | Q2 2026 | -0.24 | 0.14 | +158.33% | $200.6M | ✅ Beat | +22.83% | +14.36% | +17.81% |
| 2026-05-04 | Q1 2026 | -0.28 | 0.10 | +135.71% | $204.6M | ✅ Beat | -12.02% | -20.95% | -26.26% |
| 2026-02-11 | Q4 2025 | 0.69 | 1.65 | +139.13% | $269.1M | ✅ Beat | -12.55% | -12.36% | -14.06% |
| 2025-11-03 | Q3 2025 | -0.14 | 0.38 | +371.43% | $224.5M | ✅ Beat | +15.33% | +16.77% | +82.81% |
| 2025-08-04 | Q2 2025 | 0.21 | 0.45 | +114.29% | $217.1M | ✅ Beat | -32.35% | -38.72% | -34.13% |
| 2025-05-05 | Q1 2025 | -0.23 | 0.10 | +143.48% | $201.3M | ✅ Beat | +1.98% | -1.45% | -13.12% |
| 2025-02-10 | Q4 2024 | 0.71 | 1.15 | +61.97% | $239.7M | ✅ Beat | +1.66% | -0.50% | -10.20% |
| 2024-11-04 | Q3 2024 | 0.08 | 0.60 | +650.00% | $203.2M | ✅ Beat | +3.26% | +4.84% | +2.18% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $200.6M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 93.4% | $187.3M | -9.6% | $231.6M | $193.6M | $207.2M | $214.4M |
| Non-US | 6.6% | $13.3M | +33.6% | $8.1M | $7.7M | $9.9M | $10.1M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.